Sanne de Jong

1.0k total citations
21 papers, 769 citations indexed

About

Sanne de Jong is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Sanne de Jong has authored 21 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Sanne de Jong's work include Cardiac electrophysiology and arrhythmias (6 papers), Cardiovascular Effects of Exercise (5 papers) and Cardiac Fibrosis and Remodeling (4 papers). Sanne de Jong is often cited by papers focused on Cardiac electrophysiology and arrhythmias (6 papers), Cardiovascular Effects of Exercise (5 papers) and Cardiac Fibrosis and Remodeling (4 papers). Sanne de Jong collaborates with scholars based in Netherlands, Australia and United States. Sanne de Jong's co-authors include Harold V.M. van Rijen, Toon A.B. van Veen, Jacques M.T. de Bakker, Marc A. Vos, Roel van der Nagel, John A. Jansen, Jacques M de Bakker, Mèra Stein, Mario Delmar and Maartje Noorman and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Sanne de Jong

20 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanne de Jong Netherlands 10 523 249 107 90 60 21 769
Thuy Pham United States 13 420 0.8× 273 1.1× 93 0.9× 85 0.9× 28 0.5× 23 717
Takeshi Kashimura Japan 16 595 1.1× 337 1.4× 121 1.1× 116 1.3× 32 0.5× 59 793
Marie‐Claude Drolet Canada 18 646 1.2× 236 0.9× 140 1.3× 71 0.8× 29 0.5× 35 969
Xue-si Wu China 10 242 0.5× 169 0.7× 140 1.3× 76 0.8× 22 0.4× 28 472
Minna Marttila Finland 12 517 1.0× 338 1.4× 126 1.2× 38 0.4× 41 0.7× 14 845
Shaowei Zhuang China 16 355 0.7× 276 1.1× 131 1.2× 64 0.7× 127 2.1× 35 695
Changqing Du China 13 137 0.3× 231 0.9× 90 0.8× 39 0.4× 37 0.6× 36 466
Darwin Jeyaraj United States 15 436 0.8× 494 2.0× 41 0.4× 26 0.3× 69 1.1× 20 842
Felix Hohendanner Germany 14 517 1.0× 226 0.9× 65 0.6× 53 0.6× 13 0.2× 42 696
Florian Stöckigt Germany 18 512 1.0× 250 1.0× 71 0.7× 33 0.4× 27 0.5× 38 813

Countries citing papers authored by Sanne de Jong

Since Specialization
Citations

This map shows the geographic impact of Sanne de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanne de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanne de Jong more than expected).

Fields of papers citing papers by Sanne de Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanne de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanne de Jong. The network helps show where Sanne de Jong may publish in the future.

Co-authorship network of co-authors of Sanne de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Sanne de Jong. A scholar is included among the top collaborators of Sanne de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanne de Jong. Sanne de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ovchinnikov, Dmitry A., Sanne de Jong, Saul A. Mullen, et al.. (2025). An iPSC line (FINi102-A) carrying a heterozygous R950Q variant in KCNT1 from a boy with early-onset epilepsy. Stem Cell Research. 88. 103826–103826.
2.
Jin, Jennifer, Sanne de Jong, Dario Strbenac, et al.. (2025). PARKIN protein-deficient iPSC line (FINi006-A) from an early-onset Parkinson’s disease female patient. Stem Cell Research. 87. 103795–103795. 1 indexed citations
3.
Jong, Sanne de, et al.. (2024). Value of Extended Arrhythmia Screening in Adult Congenital Heart Disease Patients. Arrhythmia & Electrophysiology Review. 13. e07–e07. 1 indexed citations
4.
6.
Jin, Jian‐Ping, Sanne de Jong, Dario Strbenac, et al.. (2023). Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene. Stem Cell Research. 73. 103211–103211. 3 indexed citations
7.
Woike, Nina, Sanne de Jong, Sabine Versteeg, et al.. (2019). Intra-articular injection of triamcinolone acetonide in a sustained release polyesteramide formulation shows prolonged anti-inflammatory efficacy in a rat model. Osteoarthritis and Cartilage. 27. S418–S419. 1 indexed citations
8.
Ellenbroek, Guilielmus H.J.M., Judith J. de Haan, Maike A. D. Brans, et al.. (2017). Leukocyte-Associated Immunoglobulin-like Receptor-1 is regulated in human myocardial infarction but its absence does not affect infarct size in mice. Scientific Reports. 7(1). 18039–18039. 9 indexed citations
9.
Jong, Sanne de, et al.. (2016). Endogenous assessment of diffuse myocardial fibrosis in patients with T-mapping. Journal of Magnetic Resonance Imaging. 45(1). 132–138. 31 indexed citations
10.
Fontes, Magda S. C., Arianne van Koppen, Sanne de Jong, et al.. (2015). Arrhythmogenic Remodeling in Murine Models of Deoxycorticosterone Acetate-Salt-Induced and 5/6-Subtotal Nephrectomy-Salt-Induced Cardiorenal Disease. Cardiorenal Medicine. 5(3). 208–218. 10 indexed citations
11.
Hout, Gerardus P. J. van, Wouter W. van Solinge, Crystel M. Gijsberts, et al.. (2015). Elevated mean neutrophil volume represents altered neutrophil composition and reflects damage after myocardial infarction. Basic Research in Cardiology. 110(6). 58–58. 19 indexed citations
12.
Jong, Sanne de, Jacques M.T. de Bakker, Marti F.A. Bierhuizen, et al.. (2014). Ex Vivo and in Vivo Administration of Fluorescent CNA35 Specifically Marks Cardiac Fibrosis. Molecular Imaging. 13(10). 6 indexed citations
13.
Jansen, John A., Toon A.B. van Veen, Sanne de Jong, et al.. (2012). Reduced Cx43 Expression Triggers Increased Fibrosis Due to Enhanced Fibroblast Activity. Circulation Arrhythmia and Electrophysiology. 5(2). 380–390. 75 indexed citations
14.
Jong, Sanne de, Jaco J.M. Zwanenburg, Fredy Visser, et al.. (2011). Direct detection of myocardial fibrosis by MRI. Journal of Molecular and Cellular Cardiology. 51(6). 974–979. 35 indexed citations
15.
16.
Jong, Sanne de, Toon A.B. van Veen, Jacques M.T. de Bakker, Marc A. Vos, & Harold V.M. van Rijen. (2011). Biomarkers of Myocardial Fibrosis. Journal of Cardiovascular Pharmacology. 57(5). 522–535. 84 indexed citations
17.
Jong, Sanne de, Toon A.B. van Veen, J. M. T. de Bakker, & Harold V.M. van Rijen. (2011). Monitoring cardiac fibrosis: a technical challenge. Netherlands Heart Journal. 20(1). 44–48. 34 indexed citations
18.
Jansen, John A., Toon A van Veen, Sanne de Jong, et al.. (2010). Abstract 19348: Reduced Cx43 Expression Leads to Increased Fibrosis and Pro-arrhythmia due to Enhanced Fibroblast Activity in Aged and Pressure Overloaded Mice. Circulation. 122. 1 indexed citations
19.
Jong, Sanne de, Toon A.B. van Veen, Harold V.M. van Rijen, & Jacques M.T. de Bakker. (2010). Fibrosis and Cardiac Arrhythmias. Journal of Cardiovascular Pharmacology. 57(6). 630–638. 267 indexed citations
20.
Jalving, Mathilde, Jan J. Koornstra, Sanne de Jong, Elisabeth G.E. de Vries, & Jan H. Kleibeuker. (2005). Review article: the potential of combinational regimen with non‐steroidal anti‐inflammatory drugs in the chemoprevention of colorectal cancer. Alimentary Pharmacology & Therapeutics. 21(4). 321–339. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026